New Drugs for Psychosis & Schizophrenia: FDA Reviews Nuplazid Safety
The Lancet May 5 2018 FDA Pimavanserin review
Posts in category Access to Affordable Medicines
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaDrug PoliticsHealthcare Politics
Canada Considers Fairer Pharma Prices
Ottawa is under pressure to do something bold. Spending by governments on patented drugs costing more than $10 000 per patient annually increased 60% last year, and spending on brand-name …
Medicine costs drive seniors to food banks
Over the past decade, the share of food bank users over age 65 increased from 3% to 7% in Toronto. Last year alone, there was a 27% jump in seniors …
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaCanadian Science PolicyDrug Politics
Canada Repulses Pharma’s NAFTA Patent Case
CMAJ April 18 2017 Canada Wins Legal Battle to Set Patent Rules
Access to Affordable MedicinesAddiction, Depression, Psychosis, SchizophreniaBusinessDrug PoliticsHealthcare PoliticsHealthcare Privatization: A Global Business CampaignHepatitis Neglect
Big Pharma Versus Everyone
Big Pharma Versus Everyone RoB Magazine November 2016